|Bid||0.88 x 1800|
|Ask||0.98 x 2200|
|Day's Range||0.8060 - 0.9110|
|52 Week Range||0.6400 - 4.8000|
|Beta (3Y Monthly)||1.69|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
CEO Jim Schutz and CFO Robert Miller Step DownFrederick (Bubba) Sandford Appointed as New CEO and Interim CFO and will Join the Board PETALUMA, Calif., Dec. 14, 2018 -- Sonoma.
If you own shares in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure Read More...
NEW YORK, NY / ACCESSWIRE / November 16, 2018 / Pharmaceutical companies Arena Pharmaceuticals and Sonoma Pharmaceuticals were in the green on Thursday. While Sonoma did not have any news to note, Arena Pharmaceuticals announced that it has entered into a lucrative licensing agreement with United Therapeutics. Arena Pharmaceuticals, Inc. shares were up 22.62% yesterday on around 4.7 million shares traded.
A look at the shareholders of Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, Read More...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA ) will be discussing their earnings results in their Q1 Earnings Call to be held on August 8, 2018 at 4:30:00 PM ...
While small-cap stocks, such as Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) with its market cap of US$16.23m, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 13) ABIOMED, Inc. (NASDAQ: ABMD ) AngioDynamics, Inc. (NASDAQ: ...
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) is a small-cap stock with a market capitalization of US$18.21M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...